Block Novo Holdings' USD16.5B Catalent acquisition: Consumer Groups Urge FTC over antitrust concerns MD Bureau19 Oct 2024 11:30 AM ISTThe deal could constrain options for competitors such as Amgen, Pfizer, Roche, and AstraZeneca , who are reportedly developing their own GLP 1 drugs.
Pfizer Hemophilia drug Hympavzi Receives USFDA Approval MD Bureau14 Oct 2024 2:08 PM ISTPfizer announced on Friday that the U.S. Food and Drug Administration has granted approval for its once-weekly injection designed to treat the two...
FDA Approves New treatment option for cutting bleeding in Hemophilia A or B Dr. Kamal Kant Kohli12 Oct 2024 11:00 AM ISTHemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX),...
GSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuits Ruchika Sharma10 Oct 2024 6:17 PM ISTNew York: Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S. state courts,...
Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine Ruchika Sharma9 Oct 2024 2:33 PM ISTLondon: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...
Pfizer Gets CDSCO Panel Nod to Study PF-06823859 Dr. Divya Colin8 Oct 2024 6:00 PM ISTNew Delhi:The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer gets CDSCO Panel nod to study antimicrobial FDC Avibactam plus Aztreonam Dr. Divya Colin30 Sept 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Active Surveillance Study: CDSCO Panel Tells Pfizer on Abrocitinib tablets Dr. Divya Colin26 Sept 2024 6:00 PM ISTNew Delhi: In line with the drug major Pfizer Products proposal to waive the specific condition mentioned in the import and marketing permission of...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal to Study Aztreonam and Avibactam Dr. Divya Colin21 Sept 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal for antimicrobial drug Sisunatovir study Dr. Divya Colin9 Sept 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Pfizer gets CDSCO Panel nod to import, and market Aztreonam plus Avibactam Powder Dr. Divya Colin2 Sept 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain MD Bureau Team1 Sept 2024 10:45 AM ISTBengaluru: The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID...
